Kazia Therapeutics (KZIA) Income from Continuing Operations (2009 - 2011)
Kazia Therapeutics (KZIA) posted Income from Continuing Operations of 926122.02 for Q4 2011, up 81.99% on a QoQ basis from 5142472.41 in Q4 2010, and up 81.99% year-over-year from 508884.19 in Q4 2010.
Kazia Therapeutics (KZIA) has 3 years of Income from Continuing Operations data on file, last reported at 926122.02 in Q4 2011.
- In Q4 2011, Income from Continuing Operations rose 81.99% year-over-year to 926122.02; the TTM figure through Dec 2011 stood at 6333253.98 (up 62.92% YoY), while the FY2025 annual figure was 13258248.17, up 24.87% from the prior year.
- Income from Continuing Operations advanced to 926122.02 in Q4 2011, from 5142472.41 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 926122.02 in Q4 2011 and bottomed at 5811839.7 in Q4 2009.
- A 3-year average of 3960144.71 and a median of 5142472.41 in 2010 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2010 — Income from Continuing Operations increased 11.52% — and 2011, when it soared 81.99%.
- Year by year, Income from Continuing Operations stood at 5811839.7 in 2009, then climbed by 11.52% to 5142472.41 in 2010, then soared by 81.99% to 926122.02 in 2011.
- The last three Income from Continuing Operations figures came in at 926122.02 (Q4 2011), 5142472.41 (Q4 2010), and 5811839.7 (Q4 2009), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -8.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.40 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Kazia Therapeutics | 1.55 Bn | 1.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | -926,122.02 |
| Dec 31, 2010 | -5.14 Mn |
| Dec 31, 2009 | -5.81 Mn |